Absci (ABSI) Stock
$9.97
−7.69% Close Nov 10
ABSI stock is in an uptrend, sits in Weinstein Stage 2 (advancing) and meets the Minervini Trend Template
Open interactive chartABSI stock price and performance
ABSI stock trades on the NASDAQ and belongs to the Healthcare sector and Biotechnology industry. Absci Corporation is headquartered in Vancouver, WA, United States.
- Last close
- $9.97
- Day range
- $9.68 to $10.92
- 52-week range
- $2.24 to $12.55
- From 52-week high
- −20.5%
- Average volume (50 days)
- 4.0M
- 1 week
- −0.3%
- 1 month
- +3.1%
- 3 months
- +5.0%
- Year to date
- +185.7%
- 1 year
- +199.0%
- 3 years
- +602.1%
- 5 years
- −38.3%
Is ABSI stock in an uptrend?
Yes, ABSI stock is in an uptrend: it meets the Minervini Trend Template criteria and 1 of the 2 Daily Pivot Breakout momentum filters is active. Price is above its 200-day moving average.
ABSI stock is in an uptrend by the trend rules on this page. It meets the Minervini Trend Template, which checks that the 50-day, 150-day and 200-day moving averages are stacked in order and that the position in the yearly range passes its check. The Daily Pivot Breakout momentum filters measure the 100-day rate of change and the 100-day EMA slope, each compared with a minimum. Under Weinstein's method, ABSI is in Stage 2 (advancing), which looks at a 30-week moving average and Mansfield relative strength to judge the stock's trend.
- Daily Pivot momentum filters
- 1 of 2 active
- 100-day ROC
- +34.6% filter at 40%: off
- 100-day EMA slope
- +92.1% filter at 25%: active
- Trend state
- Uptrend
- Minervini Trend Template
- Met on Nov 10
- 50-day average
- Above
- 150-day average
- Above
- 200-day average
- Above
- 200-day slope (1 month)
- +11.24%
- ATR (14) % of price
- 11.47%
Momentum filters from the Daily Pivot Breakout indicator: 100-day rate of change and 100-day EMA slope, each against its minimum.
Is ABSI stock in a Stage 2 uptrend?
Yes, ABSI stock is in a Stage 2 uptrend by our Weinstein stage analysis: its price is above a rising 30-week moving average and it is outperforming SPY. It also meets the Minervini Trend Template.
- Weinstein stage
- Stage 2 (advancing)
- 30-week SMA
- $8.39
- 30-week slope (4 weeks)
- +12.52%
- Mansfield RS vs SPY
- 59.86
- Weeks in Stage 2
- 31
Weinstein stage analysis uses weekly closes against the 30-week moving average and Mansfield relative strength versus SPY. See the free Stage 2 stocks screener.
ABSI support and resistance levels
The levels table for ABSI stock marks the pivot high, the pivot low and the moving-average lines. Pivot high and pivot low lines mark swing points identified on the chart, and moving-average lines plot the averages used in the trend checks. Readers compare the live price with these lines in the table and chart, which update every session, and the distances are left to that table.
| Level | Price | From close |
|---|---|---|
| Daily Pivot resistance (pivot high) | $12.55 | +25.8% |
| 9-day EMA | $10.22 | +2.5% |
| 21-day EMA | $10.07 | +1.0% |
| 50-day SMA | $9.63 | −3.4% |
| 30-week SMA | $8.39 | −15.8% |
| Latest Daily Pivot low | $8.12 | −18.6% |
| 150-day SMA | $8.06 | −19.2% |
| 200-day SMA | $6.74 | −32.4% |
Levels above the close act as resistance, levels below as support. Last close $9.97.
ABSI breakout and scanner signals
ABSI stock is tracked by the VCP, RSI Divergence, Weinstein Stage Analysis, Daily Pivot Breakout, Minervini Trend Template, Episodic Pivot, Ichimoku TK cross, 9/21 EMA cross, Golden / Death Cross and RS Rating scanners. The signal table lists the dates and directions of these scanner signals as they update. Each scanner looks at a different pattern, so readers can compare them side by side.
| Scanner | Last signal (free view, 5 sessions late) | Past year |
|---|---|---|
| VCP | None in the last year | 0 |
| RSI Divergence | Jun 5, 2026 (bearish)A more recent signal (last 5 sessions) is in the journal. | 1 |
| Weinstein Stage Analysis | Nov 3, 2026A more recent signal (last 5 sessions) is in the journal. | 125 |
| Daily Pivot Breakout | Oct 29, 2026 | 6 |
| Minervini Trend Template | Nov 3, 2026A more recent signal (last 5 sessions) is in the journal. | 80 |
| Episodic Pivot | None in the last year | 0 |
| Ichimoku TK cross | Oct 29, 2026 | 6 |
| 9/21 EMA cross | Oct 27, 2026 | 6 |
| Golden / Death Cross | May 5, 2026 | 1 |
| RS Rating | Nov 3, 2026A more recent signal (last 5 sessions) is in the journal. | 111 |
ABSI seasonality by month
ABSI stock has historically been strongest in December and weakest in November, based on the monthly pattern on this page. The seasonality view summarizes how the stock's returns have tended to fall across calendar months. Past monthly patterns do not set expectations for any future month.
- Jan+10.6%40% up
- Feb+6.5%60% up
- Mar−8.5%40% up
- Apr+3.4%40% up
- May+3.3%40% up
- Jun+2.6%20% up
- Jul+12.8%60% up
- Aug−8.3%33% up
- Sep−6.4%33% up
- Oct+11.7%83% up
- Nov−13.4%20% up
- Dec+21.8%40% up
Average monthly return over 5+ years of stored daily closes, and the share of years each month closed higher.
ABSI earnings history
ABSI stock last reported quarterly results on Aug 11, 2026, and they came in below the estimate. The earnings line gives only the date and result of the last reported quarter, with the estimate comparison stated in words. Financial statements for the company are also available on the page.
| Reported | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Aug 11, 2026 | $-0.20 | $-0.21 | −5.0% |
| May 7, 2026 | $-0.20 | $-0.19 | +5.0% |
| Apr 14, 2026 | $0.44 | $0.48 | +9.1% |
| Mar 24, 2026 | $-0.17 | $-0.23 | −35.3% |
| Jan 29, 2026 | $6.45 | $6.57 | +1.9% |
ABSI bull and bear case
ABSI stock has a bullish trend state, with the trend state set to uptrend and the Weinstein stage at Stage 2 (advancing). The Minervini Trend Template is met, which supports the bullish reading. The main bearish factor in these inputs is the last reported quarter, which came in below the estimate.
What looks strong
- Stage 2 uptrend by our Weinstein stage analysis scanner.
- 1 of 2 Daily Pivot momentum filters is active (100-day ROC 34.6%, 100-day EMA slope 92.1%).
- Met the Minervini Trend Template on 2026-11-10.
- The 50, 150 and 200-day averages are stacked in uptrend order.
- Price is above a rising 200-day moving average.
- Had a Daily Pivot Breakout on 2026-10-29.
What looks weak
- Short interest is 26.24% of shares outstanding.
- Net income over the last 12 months is negative.
- Beta is 2.19, so the stock has moved much more than the market.
Drawn only from the data on this page. Not a recommendation.
ABSI news and SEC filings, last 30 days
The filings table for ABSI stock lists the company's SEC filings. Each entry shows the form type and its date, so readers can scan the filing history next to the price chart. The table updates as new filings appear.
Source: SEC EDGAR.
ABSI insider trading and risks
The insider table for ABSI stock lists trades reported by company insiders. Each row shows the transaction direction, so readers can see whether insiders are adding or reducing their holdings. The table updates as new reports are filed.
- Buys, last 90 days
- 0 ($0)
- Sales, last 90 days
- 0 ($0)
- Buys, last 12 months
- 0 ($0)
- Sales, last 12 months
- 0 ($0)
Risk flags from the data
- Short interest is 26.24% of shares outstanding.
- Net income over the last 12 months is negative.
- Beta is 2.19, so the stock has moved much more than the market.
Insider trades: SEC Form 4 open-market purchases and sales.
ABSI valuation and fundamentals
ABSI stock has valuation data on this page, and the valuation table shows the measures available for the company. The table is live and updates along with the price. This text does not state any of the valuation values.
- Market cap
- $1.75B
- Enterprise value
- $1.41B
- P/E (trailing)
- -12.1
- P/E (forward)
- -13.5
- PEG
- 0.97
- Price to sales
- 1,032.32
- Price to book
- 6.54
- EV to EBITDA
- -11.8
- Gross margin
- –
- Operating margin
- −10,741.5%
- Profit margin
- 0.0%
- Return on equity
- −57.7%
- Revenue (TTM)
- $1.6M
- Revenue growth (quarter, y/y)
- −46.4%
- Cash
- $201.1M
- Debt
- $3.8M
- Beta
- 2.19
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $2.8M | −$115.2M | −$92.9M |
| 2024 | $4.5M | −$103.1M | −$67.3M |
| 2023 | $5.7M | −$110.6M | −$84.3M |
| 2022 | $5.7M | −$104.9M | −$97.4M |
ABSI dividends and splits
ABSI stock does not pay a dividend. The dividend table lists the dates and amounts of any payments and sits alongside the other tables on the page. Because the company does not pay a dividend, the table has no payments to show for this stock.
- Dividend yield
- 0.00%
Who owns ABSI?
- Shares outstanding
- 171.6M
- Float
- 163.6M
- Held by insiders
- +11.8%
- Held by institutions
- +87.8%
- Short interest (% of shares)
- +26.2%
- Days to cover
- 8.2
What does Absci Corporation do?
Absci Corporation is a clinical-stage biopharmaceutical company that discovers and designs protein-based therapeutics. It uses generative artificial intelligence and synthetic biology, combining AI-driven modeling with high-throughput wet lab work to create antibody and other biologic candidates. Its pipeline spans immunology, oncology, inflammatory disease and dermatology, and it works with pharmaceutical and biotechnology partners on discovery and development. The company is headquartered in Vancouver, Washington.
- CEO
- Mr. Sean McClain
- Employees
- 140
- Headquarters
- Vancouver, WA, United States
- Website
- absci.com
ABSI stock FAQ
Is ABSI stock in an uptrend?
Yes, ABSI stock is in an uptrend: it meets the Minervini Trend Template criteria and 1 of the 2 Daily Pivot Breakout momentum filters is active. Price is above its 200-day moving average.
Is ABSI stock in a Stage 2 uptrend?
Yes, ABSI stock is in a Stage 2 uptrend by our Weinstein stage analysis: its price is above a rising 30-week moving average and it is outperforming SPY. It also meets the Minervini Trend Template.
Does ABSI stock meet the Minervini Trend Template?
ABSI stock meets the Minervini Trend Template on this page. The template checks that the 50-day, 150-day and 200-day moving averages are stacked in order and includes a check on the position in the yearly range.
What are ABSI stock's support and resistance levels?
The levels table for ABSI stock marks the pivot high, the pivot low and the moving-average lines. Readers compare the live price with these lines in the table and chart, which update every session.
When did ABSI last report earnings?
ABSI stock last reported quarterly results on Aug 11, 2026, and they came in below the estimate. The earnings line gives the date and result of that last reported quarter.
Are insiders buying or selling ABSI stock?
The insider table for ABSI stock lists trades reported by company insiders, with the transaction direction shown for each row. The table updates as new reports are filed.
What is ABSI stock's best and worst month historically?
ABSI stock has historically been strongest in December and weakest in November, based on the monthly pattern on this page. Past monthly patterns do not set expectations for future months.
Does ABSI stock pay a dividend?
ABSI stock does not pay a dividend. The dividend table on the page lists dates and amounts of any payments.
What are the main bullish and bearish factors for ABSI stock?
The bullish factors for ABSI stock are the uptrend trend state, the Stage 2 (advancing) Weinstein stage and the met Minervini Trend Template. The main bearish factor is the last reported quarter, which came in below the estimate.
What does ABSI do?
ABSI stock represents Absci Corporation, a clinical-stage biopharmaceutical company that designs protein-based therapeutics. It combines generative artificial intelligence and synthetic biology to create antibody and other biologic candidates for complex diseases.
What sector and industry is ABSI stock in?
ABSI stock is in the Healthcare sector and the Biotechnology industry. It trades on the NASDAQ.
